v3.26.3
Segments - Schedule of Information by Segment of the Operations for the Year Ended (Details)
6 Months Ended
Jun. 30, 2026
USD ($)
Jun. 30, 2026
CNY (¥)
Jun. 30, 2025
CNY (¥)
Schedule of Information by Segment of the Operations for the Year Ended [Line Items]      
Net revenue $ 27,265,664 ¥ 185,000,259 ¥ 174,469,851
Less:      
Cost of revenues (23,540,807) (159,726,732) (146,152,450)
Reconciliation of segment loss:      
Impairment on long-lived assets and long-term assets 67,282 456,520 2,041,299
Other income 196,601 1,333,963 28,027
Other expense 8,713 59,121 130,291
Government grants 11,292 76,619 148,000
Loss before income tax (35,092,048) (238,103,057) (19,885,492)
Operating Segment [Member]      
Schedule of Information by Segment of the Operations for the Year Ended [Line Items]      
Net revenue 27,265,664 185,000,259 174,469,851
Less:      
Cost of revenues (23,540,807) (159,726,732) (146,152,450)
Salaries and welfare (2,079,301) (14,108,267) (11,872,209)
Commissions to doctors (2,204,588) (14,958,350) (12,590,966)
Consultancy and professional service fees (696,096) (4,723,082) (6,447,195)
Advertising and promotion costs (254,006) (1,723,456) (3,676,600)
Contracted development and research service fees (15,395,617) (104,460,801)  
Other segment items [1] (928,984) (6,303,255) (5,149,162)
Segment loss (17,833,735) (121,003,684) (11,418,731)
Reconciliation of segment loss:      
Impairment on long-lived assets and long-term assets (67,282) (456,520) (2,041,299)
Other professional service fees (16,488,029) (111,872,922)  
Other income 196,601 1,333,963 28,027
Other expense (8,713) (59,121) (130,291)
Interest expense (902,182) (6,121,392) (6,471,198)
Government grants 11,292 76,619 148,000
Loss before income tax (35,092,048) (238,103,057) (19,885,492)
Operating Segment [Member] | Internet hospital [Member]      
Schedule of Information by Segment of the Operations for the Year Ended [Line Items]      
Net revenue 14,776,010 100,256,709 67,161,426
Less:      
Cost of revenues (11,244,026) (76,291,840) (39,984,734)
Salaries and welfare (1,848,129) (12,539,740) (10,611,116)
Commissions to doctors (2,204,588) (14,958,350) (12,590,966)
Consultancy and professional service fees (695,658) (4,720,112) (6,447,195)
Advertising and promotion costs (208,759) (1,416,450) (2,406,666)
Contracted development and research service fees (15,395,617) (104,460,801)  
Other segment items [1] (808,012) (5,482,449) (4,344,401)
Segment loss (17,628,779) (119,613,033) (9,223,652)
Operating Segment [Member] | Pharmaceutical supply chain [Member]      
Schedule of Information by Segment of the Operations for the Year Ended [Line Items]      
Net revenue 12,489,654 84,743,550 107,308,425
Less:      
Cost of revenues (12,296,781) (83,434,892) (106,167,716)
Salaries and welfare (231,172) (1,568,527) (1,261,093)
Commissions to doctors
Consultancy and professional service fees (438) (2,970)
Advertising and promotion costs (45,247) (307,006) (1,269,934)
Contracted development and research service fees  
Other segment items [1] (120,972) (820,806) (804,761)
Segment loss $ (204,956) ¥ (1,390,651) ¥ (2,195,079)
[1] For each reportable segment, the other segment item category primarily includes shipping expenses, rental costs, entertainment expense, office expense and expected credit losses.